Can MM, Kaymaz C. Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment. Anatol J Cardiol. 2010 ;10():36-42. doi: 10.5152/akd.2010.117.
Can MM, Kaymaz C. Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment. Anatol J Cardiol. 2010;10():36-42. doi: 10.5152/akd.2010.117
Can, M. M., & Kaymaz, C. (2010). Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment. The Anatolian Journal of Cardiology, 10(), 36-42. https://doi.org/10.5152/akd.2010.117
Can, M. M., and C. Kaymaz. "Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment." The Anatolian Journal of Cardiology, vol. 10, no. , 2010, pp. 36-42. https://doi.org/10.5152/akd.2010.117.
Can, M. M., C. Kaymaz. 2010. "Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment." The Anatolian Journal of Cardiology 10, no. : 36-42. https://doi.org/10.5152/akd.2010.117.
